Biora Therapeutics Inc (NAS:BIOR)
$ 0.678 0.02 (3.04%) Market Cap: 24.73 Mil Enterprise Value: 66.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Q1 2021 Progenity Inc Earnings Call Transcript

May 13, 2021 / 08:30PM GMT
Release Date Price: $58.75 (-1.67%)
Operator

Good afternoon, everyone. Welcome to the Progenity First Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode. And later, we will conduct a question and answer session and instructions will follow at that time. (Operator Instructions).

And I will now turn the call over to Robert Uhl, Managing Director with Westwicke ICR, Progenity's Investor Relations Firm.

Robert Uhl
Westwick ICR - Managing Director

Thank you, Operator. Good afternoon and welcome to Progenity's First Quarter 2021 Financial Results Conference Call. Joining me on the call are Dr. Harry Stylli, Chairman and Chief Executive Officer, and Eric d'Esparbes, Chief Financial Officer.

Before I turn the call over to Dr. Stylli, I would like to remind you that today's call will include forward-looking statements within the meaning of the federal securities laws including but not limited to the types of statements identified as forward-looking statement in our quarterly report on Form 10-Q that we will file later today. And our subsequent periodic reports

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot